Jean Franchi's most recent trade in Biodesix Inc was a trade of 8,164 Restricted Stock Units done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 8,164 | 8,164 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 6,354 | 6,354 | - | - | Stock Options (Right to Buy) | |
| Disc Medicine Inc | Jean M. Franchi | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 17 Jul 2025 | 2,031 | 63,499 | - | 59 | 119,829 | Common Stock |
| Disc Medicine Inc | Jean M. Franchi | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 10 Jul 2025 | 2,000 | 65,530 | - | 57.5 | 115,000 | Common Stock |
| Disc Medicine Inc | Jean M. Franchi | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 52.26 per share. | 16 Jun 2025 | 2,000 | 67,530 | - | 52.3 | 104,519 | Common Stock |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 92,429 | 92,429 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 42,010 | 42,010 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | Jean M. Franchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 26,368 | 0 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jean M. Franchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 26,368 | 108,140 | - | - | Common Stock | |
| Disc Medicine Inc | Jean M. Franchi | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 54.58 per share. | 18 Feb 2025 | 3,136 | 69,530 | - | 54.6 | 171,163 | Common Stock |
| Disc Medicine Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 72,666 | - | 0 | Common Stock | |
| Disc Medicine Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 60,766 | 60,766 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Disc Medicine Inc | M. Franchi Jean | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Jean Franchi M. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 36,666 | 36,666 | - | 0 | Common Stock | |
| Biodesix Inc | M. Jean Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 105,389 | 145,811 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 1.62 per share. | 03 Aug 2023 | 61,728 | 81,772 | - | 1.6 | 99,999 | Common Stock |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 40,422 | 40,422 | - | - | Restricted Stock Units | |
| Replimune Grp Inc | Jean M. Franchi | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 18.05 per share. | 16 May 2023 | 11,351 | 128,748 (0%) | 0% | 18.1 | 204,886 | Common Stock |
| Replimune Grp Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 67,500 | 67,500 | - | - | Employee Stock Option (right to buy) | |
| Replimune Grp Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 45,000 | 140,099 (0%) | 0% | 0 | Common Stock | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 7,317 | 153,150 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 62,500 | 145,833 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 83,333 | 83,333 | - | - | Restricted Stock Units | |
| Replimune Grp Inc | Jean M. Franchi | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.59 per share. | 16 May 2022 | 3,436 | 95,099 (0%) | 0% | 14.6 | 50,131 | Common Stock |
| Replimune Grp Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 78,750 | 78,750 | - | - | Employee Stock Option (right to buy) | |
| Replimune Grp Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 52,500 | 98,535 (0%) | 0% | 0 | Common Stock | |
| Biodesix Inc | Jean M. Franchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 20,044 | 20,044 | - | - | Common Stock | |
| Biodesix Inc | Jean M. Franchi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 20,044 | 0 | - | - | Restricted Stock Units | |
| Biodesix Inc | Jean M. Franchi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 20,044 | 20,044 | - | - | Restricted Stock Units | |
| Replimune Grp Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 69,050 | 69,050 | - | - | Employee Stock Option (right to buy) | |
| Replimune Grp Inc | Jean M. Franchi | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 46,035 | 46,035 (0%) | 0% | 0 | Common Stock |